Glucagon Kit
Product Images NDC 51662-1498

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Glucagon (NDC 51662-1498). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adverse (Adverse)

Table presenting adverse reactions occurring in 5% or more of healthy subjects receiving Glucagon for Injection subcutaneously. Adverse reactions include injection site swelling, erythema, vomiting, nausea, decreased blood pressure, asthenia, headache, dizziness, pallor, diarrhea, and somnolence, with corresponding percentages of patients affected.*

FDA Label Image

Clinical (Clinical)

A figure and two data tables presenting pharmacodynamic properties of Glucagon for Injection. The figure shows recovery of mean blood glucose levels after intramuscular injection of 1 mg Glucagon in type 1 diabetic men. The tables summarize time of maximal glucose concentration, onset of gastrointestinal smooth muscle relaxation, and duration of relaxation for intravenous and intramuscular routes with various doses.*

FDA Label Image

Description (Description)

Chemical structure notation of glucagon showing its amino acid sequence from His (Histidine) at position 1 to Thr (Threonine) at position 29, along with its molecular formula C153H225N43O49S and molecular weight 3483.*

FDA Label Image

Drug Interactions (Drug Interactions)

A table titled 'Clinically Significant Drug Interactions with Glucagon for Injection' detailing interactions with beta-blockers, indomethacin, anticholinergic drugs, warfarin, and insulin. It lists clinical impacts and recommended interventions for each drug interaction involving Glucagon for Injection.*

FDA Label Image

Highlights 1 (Highlights 1)

A data table listing sections of a medication label, including Indications and Usage, Dosage and Administration, Contraindications, and Warnings and Precautions, each with a hyperlink number and a date of 09/2019.*

FDA Label Image

How Supplied (How Supplied)

Data table listing presentations of Glucagon, including treatment kits and diagnostic aids. It details NDC numbers, strength of 1 mg per vial, and descriptions of each presentation, such as single-dose vials for injection and kits with sterile water for reconstitution.*

FDA Label Image

Inst 1 (Inst 1)

Illustration of the components included in the GLUCAGON kit, showing a vial containing powder with a rubber stopper and orange plastic cap, a needle cover, and a prefilled syringe containing sterile water with an attached needle, backstop, and plunger. The diagram labels each part clearly.*

FDA Label Image

Inst 2 (Inst 2)

Instructional step-by-step illustrated guide for using the GLUCAGON kit (intramuscular/intravenous). The images show detailed hand movements and actions including removing caps, drawing solution from a vial, mixing powder, attaching the syringe, injecting the solution, and appropriate disposal or final handling. Each step pairs a short textual instruction with a corresponding black-and-white line drawing diagram.*

FDA Label Image

Inst 3 (Inst 3)

Text panel listing symptoms and signs of hypoglycemia, including sweating, drowsiness, dizziness, anxiety, irritability, headache, seizures, and death, highlighting progression from early to severe hypoglycemia.*

FDA Label Image

Kit Contents And Interior Labeling (Kit Contents And Interior Labeling)

Glucagon kit by HF Acquisition Co LLC, DBA HealthFirst, includes a vial labeled 'Glucagon as Hydrochloride 1 mg' and a 1 mL syringe labeled 'Sterile Water for injection, USP' for drug diluent use. Kit comes in an orange plastic case with illustrated step-by-step preparation and injection instructions inside the lid. Intended for intramuscular and intravenous use.*

FDA Label Image

Kit Label (Kit Label)

Label for Glucagon Emergency Kit for Low Blood Sugar containing Glucagon for Injection 1 mg per vial. The label specifies the kit contains one single-dose vial with 1 mg of Glucagon for Injection and one prefilled syringe with 1 mL of Sterile Water for Injection, USP as diluent. It is labeled for subcutaneous, intramuscular, or intravenous injection. The manufacturer is Fresenius Kabi.*

FDA Label Image

Logo (Logo Inst)

FDA Label Image

Serialized Kit Labeling (Serialized 63323 582 82 Glucagon Emergency Kit Hf Label)

GLUCAGON Emergency Kit for Low Blood Sugar containing Glucagon for Injection 1 mg per vial. The orange kit box label states it includes one single-dose vial of glucagon and one prefilled syringe with 1 mL sterile water. It is intended for subcutaneous, intramuscular, or intravenous injection. Distributed by HF Acquisition Co LLC.*

FDA Label Image

Syringe Label (Syringe Label)

Label from a 1 mL single-dose syringe of Sterile Water for Injection, USP, intended for drug diluent use only. The label includes volume markings at 0.5 mL and 1 mL and is marked with the manufacturer name Fresenius Kabi.*

FDA Label Image

Vial Label (Vial Label)

Label for Glucagon for Injection (Synthetic) 1 mg per vial by Fresenius Kabi. The label states the drug is for subcutaneous, intramuscular, or intravenous injection and should be reconstituted with sterile water for injection. It includes a barcode, lot number, and expiration date section.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.